Beckman Coulter, Wyatt Ink Deal Covering Nanoparticle Characterization | GenomeWeb

NEW YORK (GenomeWeb News) – Beckman Coulter Life Sciences announced on Tuesday an agreement to collaborate with Wyatt Technology on products, applications, and technical development.

Specifically, the companies will develop products for nanoparticle characterization to be marketed under the Beckman Coulter Life Sciences brand. The deal opens up potential future collaborations on product development and the sharing of business practices, Beckman Coulter Life Sciences said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.